Outcomes | 30 days follow-up |
Death, n (%) | 4 (1.2%) |
Cardiac death, n (%) | 4 (1.2%) |
Non-cardiac death, n (%) | 0 (0) |
Myocardial infarction, n (%) | 0 (0) |
Target lesion revascularization, n (%) | 1 (0.3%) |
Target vessel revascularization, n (%) | 0 (0%) |
Overall stent thrombosis, n (%) | 1 (0.3%) |
Definite stent thrombosis, n (%) | 1 (0.3%) |
Probable stent thrombosis, n (%) | 0 (0%) |
Possible stent thrombosis, n (%) | 0 (0%) |
Major adverse cardiac events, n (%) | 5 (1.5%) |